{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:02:53Z","timestamp":1771855373875,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Self-funded Scientific Project of the Health Commission of Guangxi Zhuang Autonomous Region","award":["Z-A20240534"],"award-info":[{"award-number":["Z-A20240534"]}]},{"name":"the Guangxi Key Research and Development Program Special Fund for Science and Technology Development","award":["2024AB17049"],"award-info":[{"award-number":["2024AB17049"]}]},{"name":"the Guangxi Natural Science Foundation Key Project Joint Special Project for Research on Regional High-Incidence Diseases","award":["2023GXNSFDA026061"],"award-info":[{"award-number":["2023GXNSFDA026061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03735-8","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:35:00Z","timestamp":1769772900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-35 enhances IL-10\u207a breg-mediated immunoregulation and attenuates inflammation and fibrosis in systemic sclerosis"],"prefix":"10.1186","volume":"28","author":[{"given":"Wen","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyou","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-2128","authenticated-orcid":false,"given":"Ling","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"6","key":"3735_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","volume":"6","author":"TR Katsumoto","year":"2011","unstructured":"Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Annu Rev Pathol Mech Dis. 2011;6(6):509\u201337.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"7","key":"3735_CR2","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s10067-021-05665-z","volume":"40","author":"K Melissaropoulos","year":"2021","unstructured":"Melissaropoulos K, Daoussis D. B cells in systemic sclerosis: from pathophysiology to treatment. Clin Rheumatol. 2021;40(7):2621\u201331.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"3735_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nri2990","volume":"11","author":"RA Reilkoff","year":"2011","unstructured":"Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol. 2011;11(6):427\u201335.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3735_CR4","doi-asserted-by":"publisher","first-page":"10413","DOI":"10.1038\/s41467-024-54685-1","volume":"15","author":"CL Guo","year":"2024","unstructured":"Guo CL, Wang CS, Wang ZC, et al. Granzyme K\u2009+\u2009CD8\u2009+\u2009T cells interact with fibroblasts to promote neutrophilic inflammation in nasal polyps. Nat Commun. 2024;15(1):10413.","journal-title":"Nat Commun"},{"issue":"7","key":"3735_CR5","first-page":"999008","volume":"13","author":"CF Beesley","year":"2022","unstructured":"Beesley CF, Goldman NR, Taher TE, et al. Dysregulated B cell function and disease pathogenesis in systemic sclerosis. Front Immunol. 2022;13(7):999008.","journal-title":"Front Immunol"},{"key":"3735_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.611795","volume":"12","author":"D Catal\u00e1n","year":"2021","unstructured":"Catal\u00e1n D, Mansilla MA, Ferrier A, et al. Immunosuppressive mechanisms of regulatory B cells. Front Immunol. 2021;12:611795.","journal-title":"Front Immunol"},{"key":"3735_CR7","doi-asserted-by":"publisher","unstructured":"Choi JK, Yu CR, Bing SJ, et al. IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases. Proc Natl Acad Sci USA. 2021;118(47). https:\/\/doi.org\/10.1073\/pnas.2109548118.","DOI":"10.1073\/pnas.2109548118"},{"issue":"2","key":"3735_CR8","doi-asserted-by":"publisher","first-page":"e1082703","DOI":"10.1080\/2162402X.2015.1082703","volume":"5","author":"F Figueir\u00f3","year":"2016","unstructured":"Figueir\u00f3 F, Muller L, Funk S, et al. Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg). Oncoimmunology. 2016;5(2):e1082703.","journal-title":"Oncoimmunology"},{"issue":"12","key":"3735_CR9","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.4049\/jimmunol.1400336","volume":"193","author":"H Kaku","year":"2014","unstructured":"Kaku H, Cheng KF, Al-Abed Y, Rothstein TL. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production. J Immunol. 2014;193(12):5904\u201313.","journal-title":"J Immunol"},{"key":"3735_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2015.02.004","volume":"59","author":"A Nou\u00ebl","year":"2015","unstructured":"Nou\u00ebl A, Pochard P, Simon Q, et al. B-Cells induce regulatory T cells through TGF-\u03b2\/IDO production in A CTLA-4 dependent manner. J Autoimmun. 2015;59:53\u201360.","journal-title":"J Autoimmun"},{"key":"3735_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3389\/fimmu.2017.00768","volume":"8","author":"L Xu","year":"2017","unstructured":"Xu L, Liu X, Liu H, et al. Impairment of granzyme B-Producing regulatory B cells correlates with exacerbated rheumatoid arthritis. Front Immunol. 2017;8:768.","journal-title":"Front Immunol"},{"issue":"5","key":"3735_CR12","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/rheumatology\/keac578","volume":"62","author":"LI Sakkas","year":"2023","unstructured":"Sakkas LI, Katsiari CG, Daoussis D, Bogdanos DP. The role of B cells in the pathogenesis of systemic sclerosis: an update. Rheumatology. 2023;62(5):1780\u20136.","journal-title":"Rheumatology"},{"issue":"2","key":"3735_CR13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/art.39437","volume":"68","author":"A Mavropoulos","year":"2016","unstructured":"Mavropoulos A, Simopoulou T, Varna A, et al. Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheumatol. 2016;68(2):494\u2013504.","journal-title":"Arthritis Rheumatol"},{"issue":"20","key":"3735_CR14","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1158\/1078-0432.CCR-16-0743","volume":"22","author":"Y Pylayeva-Gupta","year":"2016","unstructured":"Pylayeva-Gupta Y. Molecular pathways: interleukin-35 in autoimmunity and cancer. Clin Cancer Res. 2016;22(20):4973\u20138.","journal-title":"Clin Cancer Res"},{"key":"3735_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01051","volume":"11","author":"M Kang","year":"2020","unstructured":"Kang M, Choi JK, Jittayasothorn Y, Egwuagu CE. Interleukin 35-producing exosomes suppress neuroinflammation and autoimmune uveitis. Front Immunol. 2020;11:1051.","journal-title":"Front Immunol"},{"key":"3735_CR16","doi-asserted-by":"crossref","unstructured":"Xie F, Hu Q, Cai Q et al. IL-35 inhibited Th17 response in children with allergic rhinitis. Orl J Oto-Rhino-lary.2020;82(1): 47\u201352.","DOI":"10.1159\/000504197"},{"issue":"8","key":"3735_CR17","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00296-018-4071-8","volume":"38","author":"J Tang","year":"2018","unstructured":"Tang J, Lei L, Pan J, et al. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis. Rheumatol Int. 2018;38(8):1511\u20139.","journal-title":"Rheumatol Int"},{"issue":"2","key":"3735_CR18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/rheumatology\/keab359","volume":"61","author":"C Yang","year":"2022","unstructured":"Yang C, Lei L, Pan J, et al. Altered CD4\u2009+\u2009T cell and cytokine levels in peripheral blood and skin samples from systemic sclerosis patients and IL-35 in CD4\u2009+\u2009T cell growth. Rheumatology. 2022;61(2):794\u2013805.","journal-title":"Rheumatology"},{"issue":"10","key":"3735_CR19","first-page":"3420","volume":"118","author":"T Matsushita","year":"2008","unstructured":"Matsushita T, Yanaba K, Bouaziz JD, et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118(10):3420\u201330.","journal-title":"J Clin Invest"},{"issue":"6","key":"3735_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","volume":"20","author":"RX Wang","year":"2014","unstructured":"Wang RX, Yu CR, Dambuza IM, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. 2014;20(6):633\u201341.","journal-title":"Nat Med"},{"issue":"5","key":"3735_CR21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","year":"1980","unstructured":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthritis rheum-us. 1980;23(5):581\u201390.","journal-title":"Arthritis rheum-us"},{"issue":"11","key":"3735_CR22","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis rheum-us. 2013;65(11):2737\u201347.","journal-title":"Arthritis rheum-us"},{"issue":"1","key":"3735_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5301\/jsrd.5000231","volume":"2","author":"D Khanna","year":"2017","unstructured":"Khanna D, Furst DE, Clements PJ, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2(1):11\u20138.","journal-title":"J Scleroderma Relat Disord"},{"issue":"4","key":"3735_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.21037\/qims.2016.08.08","volume":"6","author":"S Wangkaew","year":"2016","unstructured":"Wangkaew S, Euathrongchit J, Wattanawittawas P, Kasitanon N. Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients. Quant Imaging Med Surg. 2016;6(4):381\u201390.","journal-title":"Quant Imaging Med Surg"},{"issue":"12","key":"3735_CR25","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.humimm.2018.10.009","volume":"79","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Zhang Y, Ye J, et al. IL-35 promoted STAT3 phosphorylation and IL-10 production in B cells, but its production was reduced in patients with coronary artery diseases. Hum Immunol. 2018;79(12):869\u201375.","journal-title":"Hum Immunol"},{"issue":"3","key":"3735_CR26","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41385-019-0246-1","volume":"13","author":"R Xu","year":"2020","unstructured":"Xu R, Shears RK, Sharma R, et al. IL-35 is critical in suppressing superantigenic Staphylococcus aureus-driven inflammatory Th17 responses in human nasopharynx-associated lymphoid tissue. Mucosal Immunol. 2020;13(3):460\u201370.","journal-title":"Mucosal Immunol"},{"issue":"11","key":"3735_CR27","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2019-215208","volume":"78","author":"M Wu","year":"2019","unstructured":"Wu M, Skaug B, Bi X, et al. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis. Ann Rheum Dis. 2019;78(11):1583\u201391.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3735_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/1346-8138.17134","volume":"51","author":"T Fukasawa","year":"2024","unstructured":"Fukasawa T, Yoshizaki-Ogawa A, Sato S, Yoshizaki A. The role of B cells in systemic sclerosis. J Dermatol. 2024;51(7):904\u201313.","journal-title":"J Dermatol"},{"issue":"1","key":"3735_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13075-018-1569-0","volume":"20","author":"S Bosello","year":"2018","unstructured":"Bosello S, Angelucci C, Lama G, et al. Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. Arthritis Res Ther. 2018;20(1):75.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"3735_CR30","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s10067-015-3006-y","volume":"34","author":"AT Dantas","year":"2015","unstructured":"Dantas AT, Gon\u00e7alves SM, Pereira MC, et al. Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement. Clin Rheumatol. 2015;34(9):1621\u20135.","journal-title":"Clin Rheumatol"},{"key":"3735_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.06.003","volume":"122","author":"X Li","year":"2019","unstructured":"Li X, Fang P, Yang WY, et al. IL-35, as a newly proposed homeostasis-associated molecular pattern, plays three major functions including anti-inflammatory initiator, effector, and blocker in cardiovascular diseases. Cytokine. 2019;122:154076.","journal-title":"Cytokine"},{"issue":"12","key":"3735_CR32","first-page":"2273","volume":"54","author":"M Tomcik","year":"2015","unstructured":"Tomcik M, Zerr P, Palumbo-Zerr K, et al. Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease. Rheumatology. 2015;54(12):2273\u201382.","journal-title":"Rheumatology"},{"key":"3735_CR33","doi-asserted-by":"publisher","unstructured":"Osuna-G\u00f3mez R, Castellv\u00ed I, Mulet M et al. Impaired regulation by IL-35 in systemic sclerosis. Int J Mol Sci. 2023;24(13). https:\/\/doi.org\/10.3390\/ijms241310567.","DOI":"10.3390\/ijms241310567"},{"issue":"6","key":"3735_CR34","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/eji.201445217","volume":"45","author":"KO Dixon","year":"2015","unstructured":"Dixon KO, Van Der Kooij SW, Vignali DA, Van Kooten C. Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members. Eur J Immunol. 2015;45(6):1736\u201347.","journal-title":"Eur J Immunol"},{"issue":"2","key":"3735_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111513","volume":"383","author":"J Liu","year":"2019","unstructured":"Liu J, Chen X, Hao S, et al. Human chorionic gonadotropin and IL-35 contribute to the maintenance of peripheral immune tolerance during pregnancy through mediating the generation of IL-10\u2009+\u2009or IL-35\u2009+\u2009Breg cells. Exp Cell Res. 2019;383(2):111513.","journal-title":"Exp Cell Res"},{"issue":"4","key":"3735_CR36","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.celrep.2019.12.081","volume":"30","author":"JA Sullivan","year":"2020","unstructured":"Sullivan JA, Tomita Y, Jankowska-Gan E, et al. Treg-Cell-Derived IL-35-Coated extracellular vesicles promote infectious tolerance. Cell Rep. 2020;30(4):1039\u2013e515.","journal-title":"Cell Rep"},{"key":"3735_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cyto.2016.12.011","volume":"91","author":"M Tarique","year":"2017","unstructured":"Tarique M, Saini C, Naqvi RA, et al. Increased IL-35 producing Tregs and CD19\u2009+\u2009IL-35\u2009+\u2009cells are associated with disease progression in leprosy patients. Cytokine. 2017;91:82\u20138.","journal-title":"Cytokine"},{"key":"3735_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2021.04.050","volume":"559","author":"Y He","year":"2021","unstructured":"He Y, Pei JH, Li XQ, Chi G. IL-35 promotes EMT through STAT3 activation and induces MET by promoting M2 macrophage polarization in HCC. Biochem Biophys Res Commun. 2021;559:35\u201341.","journal-title":"Biochem Biophys Res Commun"},{"issue":"Si","key":"3735_CR39","doi-asserted-by":"publisher","first-page":"Si114","DOI":"10.1093\/rheumatology\/keac453","volume":"62","author":"R Bhandari","year":"2023","unstructured":"Bhandari R, Yang H, Kosarek NN, et al. Human dermal fibroblast-derived exosomes induce macrophage activation in systemic sclerosis. Rheumatology. 2023;62(Si):Si114-si24.","journal-title":"Rheumatology"},{"issue":"9","key":"3735_CR40","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002356RR","volume":"35","author":"M Asad","year":"2021","unstructured":"Asad M, Sabur A, Kamran M, et al. Effector functions of Th17 cells are regulated by IL-35 and TGF-\u03b2 in visceral leishmaniasis. FASEB J. 2021;35(9):e21755.","journal-title":"FASEB J"},{"issue":"4","key":"3735_CR41","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/imm.13596","volume":"168","author":"R Osuna-G\u00f3mez","year":"2023","unstructured":"Osuna-G\u00f3mez R, Barril S, Mulet M, et al. The immunoregulatory role of IL-35 in patients with interstitial lung disease. Immunology. 2023;168(4):610\u201321.","journal-title":"Immunology"},{"issue":"3","key":"3735_CR42","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jaci.2018.06.041","volume":"143","author":"MH Shamji","year":"2019","unstructured":"Shamji MH, Layhadi JA, Achkova D, et al. Role of IL-35 in Sublingual allergen immunotherapy. J Allergy Clin Immun. 2019;143(3):1131\u2013e424.","journal-title":"J Allergy Clin Immun"},{"issue":"7","key":"3735_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nri3857","volume":"15","author":"P Shen","year":"2015","unstructured":"Shen P, Fillatreau S. Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol. 2015;15(7):441\u201351.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"3735_CR44","doi-asserted-by":"publisher","first-page":"938785","DOI":"10.3389\/fimmu.2022.938785","volume":"13","author":"A Yoshizaki","year":"2022","unstructured":"Yoshizaki A, Fukasawa T, Ebata S, et al. Involvement of B cells in the development of systemic sclerosis. Front Immunol. 2022;13(7):938785.","journal-title":"Front Immunol"},{"issue":"1","key":"3735_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13075-016-1213-9","volume":"19","author":"O Aravena","year":"2017","unstructured":"Aravena O, Ferrier A, Menon M, et al. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients. Arthritis Res Ther. 2017;19(1):8.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3735_CR46","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.4049\/jimmunol.1402362","volume":"195","author":"H Kudo","year":"2015","unstructured":"Kudo H, Wang Z, Jinnin M, et al. EBI3 downregulation contributes to type I collagen overexpression in scleroderma skin. J Immunol. 2015;195(8):3565\u201373.","journal-title":"J Immunol"},{"issue":"\u2013","key":"3735_CR47","doi-asserted-by":"publisher","first-page":"156501","DOI":"10.1016\/j.cyto.2024.156501","volume":"176","author":"D Bahadorian","year":"2024","unstructured":"Bahadorian D, Faraj TA, Kheder RK, et al. A glance on the role of IL-35 in systemic lupus erythematosus (SLE). Cytokine. 2024;176(\u2013):156501.","journal-title":"Cytokine"},{"issue":"23","key":"3735_CR48","doi-asserted-by":"publisher","first-page":"13600","DOI":"10.1111\/jcmm.15266","volume":"24","author":"X Xing","year":"2020","unstructured":"Xing X, Li A, Tan H, Zhou Y. IFN-\u03b3\u2009+\u2009IL-17\u2009+\u2009Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma. J Cell Mol Med. 2020;24(23):13600\u20138.","journal-title":"J Cell Mol Med"},{"issue":"null","key":"3735_CR49","doi-asserted-by":"publisher","first-page":"106924","DOI":"10.1016\/j.imlet.2024.106924","volume":"270","author":"IG Um","year":"2024","unstructured":"Um IG, Woo JS, Lee YJ, et al. IL-21 drives skin and lung inflammation and fibrosis in a model for systemic sclerosis. Immunol Lett. 2024;270(null):106924.","journal-title":"Immunol Lett"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03735-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03735-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03735-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:03:37Z","timestamp":1771851817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03735-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3735"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03735-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board (GXMUUH-2021-IRB-045), with written informed consent obtained from all participants. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}